bevacizumab

bevacizumab · BEVACIZUMAB 95.5 mg/95.5mL · Liquid · Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC

NDC 58394-0095-05 · 95.5 mL in 1 CONTAINER · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $5,276.29 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: —
TE code: —
Approval date: —
Patents / exclusivity: —

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of bevacizumab (Liquid)

Labeler	Strength	First seen	Last seen
Genentech, Inc.	BEVACIZUMAB 25 g/L	Jul 15, 2026	Sep 2, 2026
Genentech, Inc. (SSF)	BEVACIZUMAB 25 g/L	Jul 15, 2026	Sep 2, 2026
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC	BEVACIZUMAB 95.5 mg/95.5mL	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "bevacizumab — NDC 58394-0095-05," retrieved September 3, 2026, https://drugdashboards.com/drug/58394009505.

Free to cite with attribution — see how the data is put together.